When was vilazodone approval




















Healio News Psychiatry Depression. Read next. March 16, Receive an email when new articles are posted on. Please provide your email address to receive an email when new articles are posted on. You've successfully added to your alerts. You will receive an email when new content is published. Thank you for submitting a comment on this article. Your comment will be reviewed and published at the journal's discretion. Please check for further notifications by email.

Sign in Don't already have an Oxford Academic account? You could not be signed in. Sign In Forgot password? Don't have an account? Sign in via your Institution Sign in. Purchase Subscription prices and ordering for this journal Short-term Access To purchase short term access, please sign in to your Oxford Academic account above. This article is also available for rental through DeepDyve.

View Metrics. Email alerts Article activity alert. New issue alert. Receive exclusive offers and updates from Oxford Academic. Related articles in Google Scholar. Citing articles via Web of Science 2. Pharmacotherapy for nontuberculous mycobacterial pulmonary disease. Practice-enhancing publications about the medication-use process in Do we still need to be concerned about postsurgical opioid prescribing?

Data extraction: The FDA had access to original raw data sets for these trials. It needs to be taken with food to ensure adequate plasma concentrations. Vilazodone's profile of adverse events is similar to that seen with selective serotonin reuptake inhibitors. No dose adjustment is needed based on age, gender, or renal or hepatic impairment.



0コメント

  • 1000 / 1000